Researchers have made a discovery related to amyotrophic lateral sclerosis (ALS), finding that gene expression signatures from whole blood may be used to predict case status and survival. Some studies suggest that blood biomarkers could help diagnose ALS earlier, while others explore the use of plasma proteomic signatures and multi-omics frameworks to understand the disease. The exact nature and implications of these findings are not entirely clear, with various studies examining different aspects of ALS, including immune infiltration, cellular aging, and disease pathogenesis.